☆ 4.5 Article

Community-Acquired Pneumococcal Pneumonia in Highly Vaccinated Population: Analysis by Serotypes, Vaccination Status, and Underlying Medical Conditions

JOURNAL OF KOREAN MEDICAL SCIENCE (2023)

Related references

Note: Only part of the references are listed.

Article Microbiology

Prevalence of Pneumococcal Serotypes in Community-Acquired Pneumonia among Older Adults in Italy: A Multicenter Cohort Study

Andrea Orsi et al.

Summary: This study aimed to assess the serotype-specific epidemiology of pneumococci among hospitalized older adults in Italy. The prevalence of pneumococcal infection among hospitalized CAP cases was 13.1%, with serotypes 3, 8, 22F, and 11A being the most common. PCV20, which includes these serotypes, plays an important role in preventing pneumonia in older adults.

MICROORGANISMS (2023)

Add to Collection

Letter Respiratory System

A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany

Christina Bahrs et al.

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

Article Immunology

Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged >50 years: A randomized phase 3 trial (PNEU-TRUE)

Jakub K. Simon et al.

Summary: This study assessed the safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine. The results showed consistent safety profile and immune response for V114 across different manufacturing lots.

VACCINE (2022)

Add to Collection

Article Immunology

Dynamics of Invasive Pneumococcal Disease in Israel in Children and Adults in the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Era: A Nationwide Prospective Surveillance

Shalom Ben-Shimol et al.

Summary: A ten-year surveillance after the implementation of PCV7/PCV13 showed a significant reduction in invasive pneumococcal disease in children and adults, with stabilization after four years. The main PCV13 serotypes were 3, 19A, and 14, while serotypes 8 and 12F were the predominant nonvaccine serotypes.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assay

Jason J. LeBlanc et al.

Summary: This study provides updated data on pneumococcal community-acquired pneumonia (pCAP) and invasive pneumococcal disease (IPD) in hospitalized adults from 2010 to 2017 in the context of age- and risk-based pneumococcal vaccine recommendations in Canada. The results show that the risk of pneumococcal infection in adults is related to age and disease category, with differences observed among different age groups. Moreover, the study supports the direct immunization of adults with PCV13 or higher-valency conjugate vaccines to reduce the burden of pCAP and IPD, considering the insufficient herd protection from PCV13 childhood immunization or the use of PPV23 in adults.

VACCINE (2022)

Add to Collection

Article Immunology

Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in older individuals after the introduction of childhood 13-valent pneumococcal conjugate vaccine: A multicenter hospital-based case-control study in Japan

Kei Nakashima et al.

Summary: This study evaluated the effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPSV23) against all-cause pneumonia and pneumococcal pneumonia in older individuals with community-acquired pneumonia (CAP) after the introduction of childhood PCV13 in Japan. The results showed that PPSV23 was not effective against all-cause pneumonia and pneumococcal pneumonia after the introduction of childhood PCV13.

VACCINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Impact of national pneumococcal vaccination program on invasive pneumococcal diseases in South Korea

Yeon Haw Jung et al.

Summary: This study describes the epidemiology of invasive pneumococcal disease (IPD) in South Korea and highlights the changes in serotypes following the introduction of pneumococcal conjugate vaccines. The findings suggest the need for continued monitoring during the development of new vaccines.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Immunology

Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe

Germaine Hanquet et al.

Summary: We evaluated the incidence of invasive pneumococcal disease (IPD) in Europe during the 8 years of infant pneumococcal conjugate vaccine (PCV) programs using PCV10 and PCV13 vaccines. IPD incidence declined between 2011 and 2014, but increased between 2015 and 2018. The incidence of non-PCV13 serotypes increased while PCV13 serotypes decreased. Similar trends were observed in countries using PCV13 or PCV10 vaccines. The study highlights the need for new vaccines providing broader serotype protection.

EMERGING INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Invasive Disease Potential of Pneumococcal Serotypes in Children After PCV13 Implementation

Robert Cohen et al.

Summary: Most non-PCV13 serotypes had low invasive disease potential, while among serotypes with the highest invasive disease potential, most are included in PCV20 vaccine.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011-2018

Antoni Torres et al.

Summary: After 8 years of introducing PCV13 vaccine in childhood immunization program in Spain, PCV13-VT caused a substantial proportion of CAP in Spanish immunocompetent adults. Improving direct PCV13 coverage of targeted adult populations could further reduce PCV13-VT burden, and introducing PCV20 could potentially increase the benefits even further.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults

Raul Isturiz et al.

Summary: This study identified a significant proportion of hospitalized adult CAP cases associated with PCV20-unique serotypes, showing the potential of PCV20 in addressing the burden of CAP caused by additional serotypes not covered by PCV13. UAD2 detection technology played a crucial role in identifying and differentiating these serotypes.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Respiratory System

Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18

Harry Pick et al.

THORAX (2020)

Add to Collection

Article Microbiology

A New Pneumococcal Capsule Type, 10D, is the 100th Serotype and Has a Large cps Fragment from an Oral Streptococcus

Feroze Ganaie et al.

MBIO (2020)

Add to Collection

Article Immunology

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

Heather L. Platt et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2020)

Add to Collection

Article Immunology

Epidemiology of community-acquired pneumonia in the era of extended serotype-covering multivalent pneumococcal conjugate vaccines

Jung Yeon Heo et al.

VACCINE (2020)

Add to Collection

Article Infectious Diseases

Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study

Shamez N. Ladhani et al.

LANCET INFECTIOUS DISEASES (2018)

Add to Collection

Article Multidisciplinary Sciences

Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis

Jung Yeon Heo et al.

PLOS ONE (2018)

Add to Collection

Article Infectious Diseases

Adult invasive pneumococcal disease in the Republic of Korea: Risk medical conditions and mortality stratified by age group

Jong Hun Kim et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2018)

Add to Collection

Review Public, Environmental & Occupational Health

Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis

Tinevimbo Shiri et al.

LANCET GLOBAL HEALTH (2017)

Add to Collection

Review Multidisciplinary Sciences

Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis

Evelyn Balsells et al.

PLOS ONE (2017)

Add to Collection

Article Immunology

Capsular Polysaccharide (CPS) Release by Serotype 3 Pneumococcal Strains Reduces the Protective Effect of Anti-Type 3 CPS Antibodies

Eun Hwa Choi et al.

CLINICAL AND VACCINE IMMUNOLOGY (2016)

Add to Collection

Article Immunology

Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children

Emmanuelle Varon et al.

VACCINE (2015)

Add to Collection

Article Infectious Diseases

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study

Nick J. Andrews et al.

LANCET INFECTIOUS DISEASES (2014)

Add to Collection

Review Immunology

Systematic Review of the Indirect Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Pneumococcal Disease and Colonization

Jennifer D. Loo et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)

Add to Collection

Article Multidisciplinary Sciences

Impact of Preceding Flu-Like Illness on the Serotype Distribution of Pneumococcal Pneumonia

Joon Young Song et al.

PLOS ONE (2014)

Add to Collection

Review Medicine, General & Internal

Clinical Implications of Pneumococcal Serotypes: Invasive Disease Potential, Clinical Presentations, and Antibiotic Resistance

Joon Young Song et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2013)

Add to Collection

Review Multidisciplinary Sciences

Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques

Maria A. Said et al.

PLOS ONE (2013)

Add to Collection

Article Immunology

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Lisa A. Jackson et al.

VACCINE (2013)

Add to Collection

Review Infectious Diseases

Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality

T. Welte

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)

Add to Collection

Review Medicine, General & Internal

Serotype replacement in disease after pneumococcal vaccination

Daniel M. Weinberger et al.

LANCET (2011)

Add to Collection

Article Immunology

Impact of a Pneumococcal Conjugate Vaccination Program on Carriage among Children in Norway

Didrik F. Vestrheim et al.

CLINICAL AND VACCINE IMMUNOLOGY (2010)

Add to Collection

Article Immunology

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

Tamara Pilishvili et al.

JOURNAL OF INFECTIOUS DISEASES (2010)

Add to Collection

Article Immunology

Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics

Jan Poolman et al.

VACCINE (2009)

Add to Collection

Article Immunology

Antimicrobial use and serotype distribution of nasopharyngeal Streptococcus pneumoniae isolates recovered from Greek children younger than 2 years old

GA Syrogiannopoulos et al.

CLINICAL INFECTIOUS DISEASES (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.